Singapore markets close in 3 hours 36 minutes
  • Straits Times Index

    3,210.35
    -5.05 (-0.16%)
     
  • Nikkei

    32,393.33
    -285.29 (-0.87%)
     
  • Hang Seng

    17,535.37
    -193.92 (-1.09%)
     
  • FTSE 100

    7,623.99
    -59.92 (-0.78%)
     
  • Bitcoin USD

    26,344.49
    +203.31 (+0.78%)
     
  • CMC Crypto 200

    563.60
    +4.09 (+0.73%)
     
  • S&P 500

    4,337.44
    +17.38 (+0.40%)
     
  • Dow

    34,006.88
    +43.04 (+0.13%)
     
  • Nasdaq

    13,271.32
    +59.51 (+0.45%)
     
  • Gold

    1,933.60
    -3.00 (-0.15%)
     
  • Crude Oil

    89.34
    -0.34 (-0.38%)
     
  • 10-Yr Bond

    4.5420
    0.0000 (0.00%)
     
  • FTSE Bursa Malaysia

    1,445.99
    +2.54 (+0.18%)
     
  • Jakarta Composite Index

    6,984.69
    -13.69 (-0.20%)
     
  • PSE Index

    6,251.12
    +78.28 (+1.27%)
     

Company News for May 10, 2023

  • Shares of Duke Energy Corporation (DUK) declined 0.9% after the company reported first-quarter 2023 earnings of $1.20 per share, missing the Zacks Consensus Estimate of $1.29 per share.

  • Lumentum Holdings Inc.’s (LITE) shares fell 4% after the company reported third-quarter fiscal 2023 earnings of $0.75 per share, lagging the Zacks Consensus Estimate of $0.83 per share.

  • Shares of Atkore Inc. (ATKR) gained 0.5% after the company reported second-quarter fiscal 2023 earnings of $4.87 per share, beating the Zacks Consensus Estimate of $4.11 per share.

  • bluebird bio, Inc.’s (BLUE) shares jumped 12.6% after the company reported first-quarter 2023 earnings of $0.21 per share, surpassing the Zacks Consensus Estimate of a loss of $0.54 per share.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Duke Energy Corporation (DUK) : Free Stock Analysis Report

bluebird bio, Inc. (BLUE) : Free Stock Analysis Report

Lumentum Holdings Inc. (LITE) : Free Stock Analysis Report

Atkore Inc. (ATKR) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research